Clinical Trials Sponsored by OCT Clinical Trials

Total 2333 results

R-Pharm
OCT Clinical Trials

Completed

Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia

Pneumonia, Bacterial

Russian Federation
Massachusetts General Hospital
Boston Clinical Trials (BCT)

Completed

Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence

Recurrence | Major Depressive Disorder | Depression, Unipolar | Relapse

United States
R-Pharm International, LLC
Quintiles, Inc.; OCT Clinical Trials

Completed

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (CREDO 2)

Rheumatoid Arthritis

United States, Germany, Korea, Republic of, Bulgaria, Poland, Taiwan, Mexico, Hungary, Czechia, United Kingdom, Lithuania, Argentina, Brazil, Colombia, Estonia, Latvia, Russian Federation, Romania
R-Pharm International, LLC
IQVIA Pvt. Ltd; OCT Clinical Trials

Completed

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis (CREDO 4)

Rheumatoid Arthritis

Korea, Republic of, United States, Germany, Hungary, Bulgaria, Poland, Taiwan, Mexico, Czechia, Argentina, United Kingdom, Belarus, Brazil, Colombia, Estonia, Latvia, Lithuania, Russian Federation
R-Pharm International, LLC
Quintiles, Inc.; OCT Clinical Trials; Mene Research

Completed

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (CREDO 1)

Rheumatoid Arthritis

Belarus, Bulgaria, Russian Federation
R-Pharm International, LLC
Quintiles, Inc.; OCT Clinical Trials; Mene Research

Completed

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease (CREDO 3)

Rheumatoid Arthritis

United States, Korea, Republic of, Germany, Czechia, Mexico, Hungary, Poland, Argentina, Brazil, Colombia, Russian Federation
BioGaia AB
Atlantia Food Clinical Trials; CTC Clinical Trial Consultants AB

Recruiting

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

Colic, Infantile

Ireland, Sweden
Coram Clinical Trials

Completed

Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™) (IDEaL)

IVIg or SCIg Therapy in the Home or at Alternate Site

United States
Coram Clinical Trials

Completed

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry (AL1TER)

Alpha-1 Anti-trypsin Deficiency

United States
Coram Clinical Trials

Active, not recruiting

Health Evaluation And Learning for Total Parenteral Nutrition (TPN) at Home Patient Registry (HEALTH)

Malnutrition | Patients Requiring Home Parenteral Nutrition

United States
EV Clinical Trials

Completed

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

Contact Lens Discomfort | Contact Lens | Contact Lens Dryness

United States
MicuRx
Worldwide Clinical Trials

Completed

Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4

Safety
Aptinyx
Worldwide Clinical Trials

Completed

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

Diabetic Peripheral Neuropathic Pain

United States
Atlantia Food Clinical Trials

Completed

An Intervention Study Evaluating the Effects of a Raspberry Leaf Extract in an Osteoarthritic Population.

Osteoarthritis, Knee

Ireland
Atlantia Food Clinical Trials

Completed

A Study to Evaluate the Effects of a Natural Supplement in Adults With Chronic Functional Constipation

Constipation

Ireland
ProJenX
Worldwide Clinical Trials

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers (PRO-101)

Amyotrophic Lateral Sclerosis

United States
Atlantia Food Clinical Trials

Completed

Study to Investigate the Effect of Superba Boost on the Skin

Trans-epidermal Water Loss

Ireland
ProgenaBiome
Ventura Clinical Trials

Not yet recruiting

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Autism Spectrum Disorder | Autism

United States
Aptinyx
Worldwide Clinical Trials

Completed

Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

Fibromyalgia

United States
Aptinyx
Worldwide Clinical Trials

Terminated

Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

PTSD

United States
MicuRx
Worldwide Clinical Trials

Completed

Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4

Safety
Atlantia Food Clinical Trials

Terminated

Effect of Protein Hydrolysates on HbA1c Levels in Pre-diabetics

PreDiabetes

Ireland
Atlantia Food Clinical Trials

Completed

Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion

HELICOBACTER INFECTION

Ireland
Mayo Clinic
Alliance for Clinical Trials in Oncology

Terminated

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Mayo Clinic
Terumo BCT

Completed

Maintenance Plasma Exchange for Neuromyelitis Optica (MultiPLEX)

Neuromyelitis Optica | Neuromyelitis Optica Spectrum Disorder | Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis

United States
NCIC Clinical Trials Group

Terminated

Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Sleep Disorders | Nausea and Vomiting

Canada
NCIC Clinical Trials Group

Completed

Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases

Bone Metastases

Canada
NCIC Clinical Trials Group

Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada, Australia
NCIC Clinical Trials Group

Completed

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Melanoma

Canada, United States
NCIC Clinical Trials Group

Completed

Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group

Completed

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Completed

Bortezomib in Treating Patients With Mantle Cell Lymphoma

Lymphoma

Canada
NCIC Clinical Trials Group

Terminated

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (DART)

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

Head and Neck Cancer

Canada
NCIC Clinical Trials Group

Completed

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Melanoma (Skin)

Canada
NCIC Clinical Trials Group

Completed

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada
NCIC Clinical Trials Group

Completed

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Ovarian Cancer

United States, Canada, United Kingdom
NCIC Clinical Trials Group

Completed

SarCNU in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

Canada
NCIC Clinical Trials Group

Completed

Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia

Leukemia

Canada, France
NCIC Clinical Trials Group

Completed

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Quality of Life | Pain | Prostate Cancer

Canada
NCIC Clinical Trials Group

Terminated

Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

Quality of Life | Oral Complications

Canada
NCIC Clinical Trials Group

Completed

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada, United States
NCIC Clinical Trials Group

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

Breast Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Pancreatic Cancer

United States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
NCIC Clinical Trials Group

Completed

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Tamoxifen in Treating Women With High-Risk Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Canada

Clinical Trials Sponsored by OCT Clinical Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations